A switch from lysosomal degradation to secretory autophagy initiates osteogenic bone metastasis in prostate cancer
Journal of Extracellular Vesicles · 2024-11 · 13 (11)
DOI: 10.1002/jev2.70002 ↗At a glance
Journal article in Journal of Extracellular Vesicles, published online on 2024-11-05. Written by Xiaoyu Wei and 5 co-authors. Institution: Department of Orthopedics, Southwest Hospital, Third Military Medical University, Chongqing, China. Major MEDLINE topics: Prostatic Neoplasms, Autophagy, Protein Tyrosine Phosphatase, Non-Receptor Type 1, Bone Neoplasms. Cited 16 times so far (Crossref); 39 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: National Natural Science Foundation of China.
Abstract (original language)
The identification of both autophagy‐related material degradation and unconventional secretion has paved the way for significant breakthroughs linking autophagy to a plethora of physiological processes and disease conditions. However, the mechanisms that coordinate these two pathways remain elusive. Here, we demonstrate that a switch from the lysosomal degradation to a secretory autophagy pathway is governed by protein tyrosine phosphatase 1B (PTP1B, encoded by PTPN1 ). Dephosphorylation at two tyrosine residues of syntaxin17 (STX17) by PTP1B reduces autophagosome‐lysosome fusion while switching the cells to a secretory autophagy pathway. Both PTP1B overexpression and tumour‐derived extracellular vesicles (EVs) can activate the secretory autophagy pathway in osteoblasts. Moreover, we demonstrate that osteoblastic LC3+ EVs, generated via the secretory autophagy pathway, are the primary contributor to tumour‐associated bone remodelling in prostate cancer. Depletion of tumour‐derived EVs secretion or genetic ablation of osteoblastic PTP1B rescues aberrant bone remodelling and lesions, highlighting the relevance between LC3+ EVs and the formation of bone metastatic niche. Our results reveal the significance of tumour‐regulated PTP1B in the fate decision of autophagosomes, and propose a role ofLC3+ EVs in shaping the bone metastatic niche.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Orthopedics, Southwest Hospital, Third Military Medical University, Chongqing, China.
- Institute of Environment and Operational Medicine, Academy of Military Medicine Sciences, Academy of Military Sciences, Tianjin, China.
- Department of Urology, Xinqiao Hospital, Third Military Medical University, Chongqing, China.
- Institute of Cancer, Xinqiao Hospital, Third Military Medical University, Chongqing, China.
- Chongqing Key Laboratory of Immunotherapy, Chongqing, China.
- Shigatse Branch, Xinqiao Hospital, Third Military Medical University, Shigatse, China.
ORCID profiles: Qinyu Ma
Funding
- National Natural Science Foundation of China
Cite
APA
Wei, X., Liang, M., Deng, M., Zheng, J., Luo, F., & Ma, Q. (2024). A switch from lysosomal degradation to secretory autophagy initiates osteogenic bone metastasis in prostate cancer. Journal of Extracellular Vesicles, 13(11). https://doi.org/10.1002/jev2.70002
Vancouver
Wei X, Liang M, Deng M, Zheng J, Luo F, Ma Q. A switch from lysosomal degradation to secretory autophagy initiates osteogenic bone metastasis in prostate cancer. Journal of Extracellular Vesicles. 2024;13(11). doi:10.1002/jev2.70002
BibTeX
@article{Wei2024,
author = {Wei, Xiaoyu and Liang, Mengmeng and Deng, Min and Zheng, Ji and Luo, Fei and Ma, Qinyu},
title = {A switch from lysosomal degradation to secretory autophagy initiates osteogenic bone metastasis in prostate cancer},
journal = {Journal of Extracellular Vesicles},
year = {2024},
volume = {13},
number = {11},
doi = {10.1002/jev2.70002}
}
EUVIMED